GSK names Walmsley to succeed Witty

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said Emma Walmsley will succeed Sir Andrew Witty as CEO on March 31, 2017. Walmsley is CEO of GSK's Consumer Healthcare division.

GSK said in March that Witty planned to retire. He has been CEO since 2008 (see BioCentury Extra, March 17). ...